News from Bayer
February 06, 2023
Not intended for U.S. and UK Media
Bayer submits aflibercept 8 mg for regulatory approval in two major retinal eye diseases in the EU
January 31, 2023
Bayer to distribute pheromone-based biological crop protection solutions from M2i Group
January 27, 2023
Not intended for U.S. and UK Media
CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
Explore All Stories
Please enter a term to search
We found 374 results